All about ebola virus

Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be five with no deputy board...

Zinzino (publ) announces that the company's annual report for 2023 in Swedish is now published on the company's website, zinzino.com. The English version will be published within approximately 45 days. The 2024 Annual General Meeting will be held at...

Rickard Gustafson, President and CEO: "Our first quarter performance marked another step towards a more resilient and competitive SKF. In soft market conditions, we delivered a strong adjusted operating margin of 13.4%, somewhat ahead of Q1 2023. The...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...

First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat)1 for early COVID-19 outpatient treatment, funded through non-dilutive external sources, including the U.S. Department of Defense The study...

The "Software-defined Networking Market by Offering, Model (API SDN, Overlay SDN, Open SDN), Application (Control Flow, Packet Forwarding, Security Flow Open Flow Switch), End User (Data Centers, Enterprises), and Geography - Global Forecast to 2031"...

First quarter 2024 Order intake SEK 31,981 million (34,363)Order intake, at fixed exchange rates, declined by 5%Revenues SEK 29,002 million (30,968)Revenue growth, at fixed exchange rates declined by 5%Adjusted EBITA SEK 5,281 million...

Risk analysis conducted by the newly formed National Commission on Climate and Workforce Health highlights need to bolster people, business, and economic resilience CEOs acknowledge extreme weather will be one of the most critical threats to their...

Boutique civil litigation firm Aldous\Walker is pleased to announce that partners Charla Aldous and Brent Walker have been named to D Magazine's Best Lawyers in Dallas 2024 list.The list, which will appear in D Magazine's May edition, cites Ms....

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows,...

Soligenix, Inc. ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced the pricing of its public offering...

"During Q1 2024, demand continued to normalize at good levels across many of the Volvo Group's markets. Adjusted for currency, net sales were on the same level as in Q1 2023 and amounted to SEK 131.2 billion. Invoiced price continued to increase,...

Integral Molecular, a leader in providing safe research reagents for virology, announces the launch of its Virus Neutralization Assay Services enabling researchers to rapidly obtain high-quality data to advance their vaccines and...

First quarter highlights ? Driving gross margin improvements and cost efficiencies Sales declined organically[1] by -14% YoY, due to a -19% decline in Networks. Reported sales decreased to SEK 53.3 (62.6) b.Gross income excluding restructuring...

Smart Eye (STO:SEYE)(FRA:SE9) Aktiebolag (publ), reg. no. 556575-8371 (the "Company" or "Smart Eye"), with its registered office in Gothenburg, gives notice of the Annual General Meeting to be held on Friday 17 May 2024 at 16.30...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Office of Orphan Products...

SKF will publish its first quarter results for 2024 on 26 April 2024 at approximately 07:00 (CEST). Investors, analysts and media are invited to join a webcast, which will be held in English, at 08:00 (CEST). To join the webcast, please login at...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Office of Orphan Products...

The previously published notice contained erroneous information regarding the first dividend payment date. The notice below is updated with correct information. The shareholders in New Wave Group AB (publ) are hereby notified of the Annual General...

The report titled "5G in Aerospace & Defense Market by Communication Infrastructure (Macro Cell, Small Cell), Operational Frequency (High, Low, Medium), Core Network Technology, End Use - Global Forecast 2024-2030" is now available on...

The shareholders in New Wave Group AB (publ) are hereby notified of the Annual General Meeting Date and time: Thursday 16 May 2024 at 13:00 (CET) Place: Kosta Boda Art Hotel, Stora Vägen 75, SE-365 43 Kosta, Sweden...

The "Hybrid Truck Market Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The hybrid truck market has grown strongly in recent years. It will grow from $22.18 billion in 2023 to $23.74 billion in 2024 at a...

RedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base   Focused externally funded R&D: Opaganib for nuclear and chemical medical...

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidateKey takeaways:Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2...

The shareholders of Medivir AB (publ), reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the annual general meeting on Tuesday 7 May 2024 at 14.00 CEST at Helio GT30, Grev Turegatan 30, Stockholm, Sweden....

Telefonaktiebolaget LM Ericsson's Annual General Meeting (AGM) was held today on April 3, 2024 in Kista, Stockholm. Shareholders were also able to exercise their voting rights by post before the meeting. Adoption of the Income Statements and the...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received agreement from...

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand, the...

The "Business Travel - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Business Travel estimated at US$690.6 Billion in the year 2023, is projected to reach a revised size of US$928.4...